Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus-Reference-Cited by-同舟云学术

Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus

Published:2024-08 Issue:8 Volume:56 Page:1270-1280
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Olivera Pablo A.,Dignass Axel^ORCID,Dubinsky Marla C.,Peretto Giovanni,Kotze Paulo G.^ORCID,Dotan Iris,Kobayashi Taku^ORCID,Ghosh Subrata,Magro Fernando,Faria-Neto Jose Rocha,Siegmund Britta,Danese Silvio,Peyrin-Biroulet Laurent^ORCID

Funder

Pfizer

Pfizer France

Publisher

Elsevier BV

Reference130 articles.

1. Peyrin-Biroulet L. Crohn's disease;Torres;Lancet,2017

2. Ulcerative colitis;Ungaro;Lancet,2017

3. Newer biologic and small-molecule therapies for inflammatory bowel disease;Baumgart;N Engl J Med,2021

4. Next generation of small molecules in inflammatory bowel disease;Olivera;Gut,2017

5. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease;Salas;Nat Rev Gastroenterol Hepatol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management;World Journal of Gastroenterology;2024-09-21

2. Cardiovascular Risk in Patients with Inflammatory Bowel Diseases—The Role of Endothelial Dysfunction;Diagnostics;2024-08-08

3. Coronary artery calcium score for cardiovascular risk assessment in inflammatory bowel disease – Data from first pilot prospective study;Digestive and Liver Disease;2024-08

4. Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling;Heliyon;2024-07